Table 1.

Univariate analysis results for baseline plaque V_p and K^trans.

	Vp		Ktrans
Variable	r or Mean ± SD	P Value	r or Mean ± SD	P Value	No.
Sex		0.86		0.54	98
Male	0.075 ± 0.046		0.060 ± 0.025		84
Female	0.078 ± 0.051		0.055 ± 0.024		14
Age	−0.24	0.020	0.05	0.63	98
Race		0.70		0.27	98
White	0.075 ± 0.047		0.060 ± 0.025		90
Non-white/Other	0.082 ± 0.040		0.050 ± 0.021		8
Ethnicity		0.70		0.40	97
Hispanic or Latino	0.084 ± 0.045		0.048 ± 0.029		4
Not Hispanic or Latino	0.075 ± 0.047		0.059 ± 0.025		93
Tobacco use		0.51		0.21	98
Current	0.085 ± 0.047		0.067 ± 0.028		21
Former (quit > 1 year ago)	0.071 ± 0.046		0.058 ± 0.023		48
Never used	0.077 ± 0.049		0.055 ± 0.024		29
Duration of statin therapy		0.011		0.50	98
<1 year	0.100 ± 0.043		0.056 ± 0.023		21
1 - 5 years	0.076 ± 0.047		0.057 ± 0.025		39
>5 years	0.062 ± 0.044		0.063 ± 0.026		38
Prior use of niacin		0.41		0.72	98
Yes	0.066 ± 0.022		0.057 ± 0.020		15
No	0.077 ± 0.050		0.059 ± 0.026		83
Metabolic syndrome		0.016		0.83	98
Present	0.081 ± 0.047		0.059 ± 0.025		79
Absent	0.053 ± 0.040		0.060 ± 0.025		19
History of diabetes		0.49		0.70	98
Yes	0.070 ± 0.047		0.057 ± 0.024		22
No	0.077 ± 0.047		0.059 ± 0.025		76
Body mass index	0.25	0.013	0.10	0.35	98
Systolic blood pressure	0.10	0.34	0.20	0.044	97
Diastolic blood pressure	0.14	0.16	0.03	0.73	97
Total cholesterol	0.04	0.70	0.01	0.89	98
LDL cholesterol	0.04	0.69	−0.04	0.68	98
Non-HDL cholesterol	0.06	0.58	0.01	0.96	98
Log(Triglycerides)	0.04	0.70	0.08	0.41	98
Log(Lipoprotein(a))	0.25	0.013	0.11	0.28	96
ApoB	0.17	0.092	0.01	0.96	96
HDL cholesterol	−0.05	0.63	0.04	0.73	98
ApoA-I	−0.01	0.92	0.02	0.84	96
Log(Total : HDL ratio)	0.09	0.40	−0.04	0.68	98
Log(ApoB : ApoA-I ratio)	0.17	0.094	−0.03	0.75	96

r = Pearson's correlation coefficient.